These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2446412)

  • 1. Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study.
    Frea B; Annoscia S; Stanta G; Lozzi C; Carmignani G
    Urol Res; 1987; 15(5):311-4. PubMed ID: 2446412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of postnecrotic and alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia.
    Cetinkaya M; Cetinkaya H; Ulusoy E; Baz S; Memiş A; Yaşa H; Yanik B; Oztürk B; Uzunalimoğlu O
    Prostate; 1998 Jul; 36(2):80-4. PubMed ID: 9655259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic hypertrophy in the elderly cirrhotic patient: an estrogenic or androgenic response?
    Van Thiel DH; Gavaler JS
    Hepatology; 1989 Jan; 9(1):167-8. PubMed ID: 2461893
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
    Partin AW; Oesterling JE; Epstein JI; Horton R; Walsh PC
    J Urol; 1991 Feb; 145(2):405-9. PubMed ID: 1703242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The origin and development of benign prostatic hyperplasia. An age-dependent process.
    Oesterling JE
    J Androl; 1991; 12(6):348-55. PubMed ID: 1722790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of benign prostatic hyperplasia and hepatic cirrhosis].
    Toppler S; Bertschinger P; Koch J; Vetter W
    Praxis (Bern 1994); 1999 Sep; 88(37):1467-74. PubMed ID: 10522457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M; Nass R; Tunn S
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
    Oesterling JE
    Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benign hypertrophy of the prostate: pathogenic aspects].
    Páez Borda A; Fernández Lucas C; Diego García A; Prieto Chaparro L; Gómez Ruiz JJ; Rapariz González M; Silmi Moyano A; Salinas Casado J; Blázquez Izquierdo J; Usón Calvo A
    Arch Esp Urol; 1991 Apr; 44(3):229-36. PubMed ID: 1714264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone and Benign Prostatic Hyperplasia.
    Rastrelli G; Vignozzi L; Corona G; Maggi M
    Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasia.
    Stege R; Carlström K
    J Steroid Biochem Mol Biol; 1992 May; 42(3-4):357-62. PubMed ID: 1376613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta.
    Huang X; Lee C
    Front Biosci; 2003 Sep; 8():s740-9. PubMed ID: 12957826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of testicular irradiation on established BPH in the dog: evidence of a non-steroidal testicular factor for BPH maintenance.
    Grayhack JT; Lee C; Brand W
    J Urol; 1985 Dec; 134(6):1276-81. PubMed ID: 2414473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endocrine environment of benign prostatic hyperplasia--relationships of sex steroid hormone levels with age and the size of the prostate].
    Suzuki K; Inaba S; Takeuchi H; Takezawa Y; Fukabori Y; Suzuki T; Imai K; Yamanaka H; Honma S
    Nihon Hinyokika Gakkai Zasshi; 1992 May; 83(5):664-71. PubMed ID: 1379658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine treatment of benign prostatic hypertrophy: current concepts.
    Matzkin H; Braf Z
    Urology; 1991 Jan; 37(1):1-16. PubMed ID: 1702565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic characterization of hereditary benign prostatic hyperplasia.
    Doehring CB; Sanda MG; Partin AW; Sauvageot J; Juo H; Beaty TH; Epstein JI; Hill G; Walsh PC
    Urology; 1996 Oct; 48(4):650-3. PubMed ID: 8886078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia. The scope of the problem.
    Grayhack JT
    Cancer; 1992 Jul; 70(1 Suppl):275-9. PubMed ID: 1376196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign prostatic hyperplasia: age-related tissue-remodeling.
    Untergasser G; Madersbacher S; Berger P
    Exp Gerontol; 2005 Mar; 40(3):121-8. PubMed ID: 15763388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.